Different Brain Opioid Receptors Control Different Metabolic Functions — Glucose, Fat, and Cortisol
Mu receptors raise blood glucose and cortisol, delta receptors raise fatty acids only, and kappa receptors raise glucose only — each opioid receptor type controls distinct metabolic outputs.
Quick Facts
What This Study Found
Mu receptor agonists raised blood glucose and corticosterone. Delta agonist raised fatty acids only. Kappa agonist raised glucose only. Mu antagonist blocked the glucose/corticosterone effects.
Key Numbers
How They Did This
Unanesthetized rats with chronic brain cannulas received third ventricle injections of four opioid agonists at multiple doses. Blood was sampled from the tail at 0, 15, 30, 60, 90, and 120 minutes.
Why This Research Matters
This study maps out how different brain opioid receptors control metabolism. The mu receptor's ability to raise blood sugar and stress hormones has implications for understanding opioid drug side effects and stress responses.
The Bigger Picture
This receptor-specific metabolic map explains why different opioid drugs have different effects on blood sugar and stress hormones. It's relevant to managing diabetic patients on opioid therapy and understanding metabolic syndrome in chronic opioid users.
What This Study Doesn't Tell Us
Animal study in rats using direct brain injections. The doses and route do not reflect normal physiology or clinical opioid use. Anesthetic-free but still invasive.
Questions This Raises
- ?Should opioid selection consider receptor-specific metabolic effects in diabetic patients?
- ?Do the metabolic effects of opioids contribute to weight gain in chronic users?
Trust & Context
- Key Stat:
- Receptor-specific metabolic control Mu, delta, and kappa opioid receptors each control distinct metabolic outputs when activated in the brain
- Evidence Grade:
- Preliminary animal study with clean pharmacological dissociation across receptor types. Brain injection route limits clinical translation.
- Study Age:
- Published in 1991. The metabolic effects of opioid receptor subtypes have been further characterized.
- Original Title:
- mu-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides.
- Published In:
- The American journal of physiology, 261(1 Pt 2), R70-81 (1991)
- Authors:
- Gunion, M W, Rosenthal, M J, Morley, J E, Miller, S, Zib, B, Butler, B, Moore, R D
- Database ID:
- RPEP-00194
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why do opioids affect blood sugar?
Opioid receptors in the brain connect to neural pathways that control liver glucose output, pancreatic hormone release, and adrenal cortisol secretion. Activating these receptors through the brain can raise blood sugar significantly.
Is this why some opioid patients gain weight?
Partly. The metabolic effects — especially mu-mediated cortisol elevation and kappa-mediated glucose changes — combined with appetite stimulation, can contribute to metabolic disruption and weight changes in chronic opioid users.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00194APA
Gunion, M W; Rosenthal, M J; Morley, J E; Miller, S; Zib, B; Butler, B; Moore, R D. (1991). mu-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides.. The American journal of physiology, 261(1 Pt 2), R70-81.
MLA
Gunion, M W, et al. "mu-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides.." The American journal of physiology, 1991.
RethinkPeptides
RethinkPeptides Research Database. "mu-receptor mediates elevated glucose and corticosterone aft..." RPEP-00194. Retrieved from https://rethinkpeptides.com/research/gunion-1991-mureceptor-mediates-elevated-glucose
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.